Split (1)

train · 21.6M rows

CUI1 stringlengths 8 8	RELA stringlengths 3 54	CUI2 stringlengths 8 8	Name1 stringlengths 1 2.86k ⌀	Name2 stringlengths 1 2.86k ⌀	Def1 stringlengths 1 8.95k ⌀	Def2 stringlengths 1 8.95k ⌀
C0000608	has_active_moiety	C5432990	6-aminocaproic acid	CALCIUM CARBONATE 36 g in 100 g / ALCLOXA 0.06 g in 100 g / AMINOCAPROIC ACID 0.06 g in 100 g / CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS 0.07 g in 100 g DENTAL PASTE, DENTIFRICE [CLEAN BREATH TOOTH]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_active_ingredient	C5449943	6-aminocaproic acid	ALCLOXA 0.05 g in 100 g / SILICON DIOXIDE 13.5 g in 100 g / AMINOCAPROIC ACID 0.05 g in 100 g DENTAL PASTE, DENTIFRICE [GREENSALTRAIN TOOTH]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_active_moiety	C5449943	6-aminocaproic acid	ALCLOXA 0.05 g in 100 g / SILICON DIOXIDE 13.5 g in 100 g / AMINOCAPROIC ACID 0.05 g in 100 g DENTAL PASTE, DENTIFRICE [GREENSALTRAIN TOOTH]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_active_ingredient	C5449951	6-aminocaproic acid	SODIUM MONOFLUOROPHOSPHATE 0.4 g in 100 g / CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS 0.07 g in 100 g / CALCIUM CARBONATE 36 g in 100 g / ALCLOXA 0.06 g in 100 g / AMINOCAPROIC ACID 0.06 g in 100 g DENTAL PASTE, DENTIFRICE [SALTRAIN TOOTH]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_active_moiety	C5449951	6-aminocaproic acid	SODIUM MONOFLUOROPHOSPHATE 0.4 g in 100 g / CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS 0.07 g in 100 g / CALCIUM CARBONATE 36 g in 100 g / ALCLOXA 0.06 g in 100 g / AMINOCAPROIC ACID 0.06 g in 100 g DENTAL PASTE, DENTIFRICE [SALTRAIN TOOTH]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_active_ingredient	C5550393	6-aminocaproic acid	SILICON DIOXIDE 16 g in 100 g / AMINOCAPROIC ACID 0.1 g in 100 g DENTAL PASTE, DENTIFRICE [Mastikis Mastic GumCare]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_active_moiety	C5550393	6-aminocaproic acid	SILICON DIOXIDE 16 g in 100 g / AMINOCAPROIC ACID 0.1 g in 100 g DENTAL PASTE, DENTIFRICE [Mastikis Mastic GumCare]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_inactive_ingredient	C5557875	6-aminocaproic acid	ALLANTOIN 2 mg in 1 mL / GLYCERIN 30 mg in 1 mL TOPICAL GEL [KAEWOON]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_active_moiety	C5563958	6-aminocaproic acid	CALCIUM CARBONATE 10.30 g in 100 g / ALCLOXA 0.05 g in 100 g / Aminocaproic Acid 0.05 g in 100 g / DIBASIC CALCIUM PHOSPHATE DIHYDRATE 0.30 g in 100 g ORAL GEL, DENTIFRICE [ROOTSALLO TOOTHPASTE]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_active_moiety	C5578614	6-aminocaproic acid	Silicon Dioxide 17.0 g in 100 g / Aminocaproic Acid 0.1 g in 100 g / ALCLOXA 0.1 g in 100 g ORAL PASTE, DENTIFRICE [Dr.LORD Green Propol Tooth]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_active_ingredient	C5813467	6-aminocaproic acid	AMINOCAPROIC ACID 0.09 g in 100 g / CALCIUM CARBONATE 37 g in 100 g / DIBASIC CALCIUM PHOSPHATE DIHYDRATE 0.09 g in 100 g / ALCLOXA 0.09 g in 100 g DENTAL PASTE, DENTIFRICE [Hea YanToothpaste]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_active_moiety	C5813467	6-aminocaproic acid	AMINOCAPROIC ACID 0.09 g in 100 g / CALCIUM CARBONATE 37 g in 100 g / DIBASIC CALCIUM PHOSPHATE DIHYDRATE 0.09 g in 100 g / ALCLOXA 0.09 g in 100 g DENTAL PASTE, DENTIFRICE [Hea YanToothpaste]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_active_ingredient	C5884740	6-aminocaproic acid	AMINOCAPROIC ACID 1 g in 1 g NOT APPLICABLE POWDER [aminocaproid acid]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_active_moiety	C5884740	6-aminocaproic acid	AMINOCAPROIC ACID 1 g in 1 g NOT APPLICABLE POWDER [aminocaproid acid]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	inverse_isa	C0003304	6-aminocaproic acid	Antifibrinolytic Agents	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders.
C0000608	has_ingredient	C0713447	6-aminocaproic acid	6-aminocaproic acid 250 MG/ML Injectable Solution [Amicar]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_ingredient	C0713516	6-aminocaproic acid	6-aminocaproic acid 250 MG/ML Oral Solution [Amicar]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_ingredient	C0713523	6-aminocaproic acid	6-aminocaproic acid 500 MG Oral Tablet [Amicar]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_ingredient	C1585092	6-aminocaproic acid	6-aminocaproic acid 1000 MG Oral Tablet [Amicar]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_member	C3539947	6-aminocaproic acid	Antifibrinolytic amino acids	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	inverse_isa	C0003304	6-aminocaproic acid	Antifibrinolytic Agents	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders.
C0000608	mapped_to	C0102946	6-aminocaproic acid	Amifer	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	mapped_to	C0661060	6-aminocaproic acid	CAPROCOL	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	inverse_isa	C0002520	6-aminocaproic acid	Amino Acids	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins.
C0000608	inverse_isa	C0003280	6-aminocaproic acid	Anticoagulants	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	Agents that prevent BLOOD CLOTTING.
C0000608	inverse_isa	C0019120	6-aminocaproic acid	Hemostatic Agents	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming...
C0000608	inverse_isa	C1320236	6-aminocaproic acid	Allergen class	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	inverse_isa	C1320237	6-aminocaproic acid	Drug allergens	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_causative_agent	C0274595	6-aminocaproic acid	Poisoning by aminocaproic acid	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_component	C0524007	6-aminocaproic acid	Aminocaproate trough measurement	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_measured_component	C0524007	6-aminocaproic acid	Aminocaproate trough measurement	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_causative_agent	C0569248	6-aminocaproic acid	Accidental aminocaproic acid poisoning	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_causative_agent	C0569249	6-aminocaproic acid	Intentional aminocaproic acid poisoning	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_causative_agent	C0569250	6-aminocaproic acid	poisoning by aminocaproic acid, undetermined intent	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_active_ingredient	C0687856	6-aminocaproic acid	6-aminocaproic acid 500 MG Oral Tablet	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_basis_of_strength_substance	C0687856	6-aminocaproic acid	6-aminocaproic acid 500 MG Oral Tablet	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_precise_active_ingredient	C0687856	6-aminocaproic acid	6-aminocaproic acid 500 MG Oral Tablet	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_active_ingredient	C1614061	6-aminocaproic acid	6-aminocaproic acid 250 MG/ML Oral Solution	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_basis_of_strength_substance	C1614061	6-aminocaproic acid	6-aminocaproic acid 250 MG/ML Oral Solution	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_precise_active_ingredient	C1614061	6-aminocaproic acid	6-aminocaproic acid 250 MG/ML Oral Solution	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_active_ingredient	C2585100	6-aminocaproic acid	Aminocaproic acid-containing product in parenteral dose form	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_active_ingredient	C2585270	6-aminocaproic acid	Aminocaproic acid-containing product in oral dose form	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_active_ingredient	C4048643	6-aminocaproic acid	6-aminocaproic acid 250 MG/ML Injection	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_component	C4736661	6-aminocaproic acid	aminocaproate in serum or plasma	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_active_ingredient	C4751829	6-aminocaproic acid	Aminocaproic acid only product	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_active_ingredient	C4755423	6-aminocaproic acid	Aminocaproic acid only product in oral dose form	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_active_ingredient	C4755424	6-aminocaproic acid	Aminocaproic acid only product in parenteral dose form	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	tradename_of	C0702045	6-aminocaproic acid	Amicar	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	isa	C0687856	6-aminocaproic acid	6-aminocaproic acid 500 MG Oral Tablet	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	isa	C1614061	6-aminocaproic acid	6-aminocaproic acid 250 MG/ML Oral Solution	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	isa	C2585100	6-aminocaproic acid	Aminocaproic acid-containing product in parenteral dose form	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	isa	C2585270	6-aminocaproic acid	Aminocaproic acid-containing product in oral dose form	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	isa	C4048643	6-aminocaproic acid	6-aminocaproic acid 250 MG/ML Injection	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	isa	C4751829	6-aminocaproic acid	Aminocaproic acid only product	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	parent_of	C2267085	6-aminocaproic acid	A [Preparations]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	parent_of	C3536773	6-aminocaproic acid	Antifibrinolytic Agent [EPC]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	tradename_of	C0702045	6-aminocaproic acid	Amicar	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_contraindicated_drug	C0012739	6-aminocaproic acid	Disseminated Intravascular Coagulation	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS.
C0000608	may_be_treated_by	C0019080	6-aminocaproic acid	Hemorrhage	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	Bleeding or escape of blood from a vessel.
C0000608	has_ingredient	C1154221	6-aminocaproic acid	6-aminocaproic acid 250 MG/ML	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_ingredient	C1154222	6-aminocaproic acid	6-aminocaproic acid 500 MG	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_ingredient	C1253129	6-aminocaproic acid	6-aminocaproic acid Oral Tablet	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_ingredient	C1253630	6-aminocaproic acid	6-aminocaproic acid Injectable Solution	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_ingredient	C1366951	6-aminocaproic acid	6-aminocaproic acid 200 MG/ML	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_ingredient	C1509861	6-aminocaproic acid	6-aminocaproic acid 1000 MG	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_ingredient	C1614614	6-aminocaproic acid	6-aminocaproic acid Oral Solution	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	mechanism_of_action_of	C2756995	6-aminocaproic acid	Enzyme Inhibitors [MoA]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	physiologic_effect_of	C2825071	6-aminocaproic acid	Decreased Fibrinolysis [PE]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_ingredient	C3207015	6-aminocaproic acid	6-aminocaproic acid Injectable Product	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_ingredient	C3207016	6-aminocaproic acid	6-aminocaproic acid Oral Liquid Product	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_ingredient	C3207017	6-aminocaproic acid	6-aminocaproic acid Oral Product	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_ingredient	C3207018	6-aminocaproic acid	6-aminocaproic acid Pill	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_ingredient	C4057516	6-aminocaproic acid	6-aminocaproic acid Injection	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	therapeutic_class_of	C4722027	6-aminocaproic acid	Blood Products/Modifiers/Volume Expanders [TC]	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_ingredient	C0687856	6-aminocaproic acid	6-aminocaproic acid 500 MG Oral Tablet	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_ingredient	C0775169	6-aminocaproic acid	6-aminocaproic acid 250 MG/ML Injectable Solution	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_ingredient	C1509250	6-aminocaproic acid	6-aminocaproic acid 1000 MG Oral Tablet	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_ingredient	C1614061	6-aminocaproic acid	6-aminocaproic acid 250 MG/ML Oral Solution	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_ingredient	C4048642	6-aminocaproic acid	20 ML 6-aminocaproic acid 250 MG/ML Injection	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000608	has_ingredient	C4082878	6-aminocaproic acid	aminocaproic acid 250 MG/ML includes Injection and Injectable Solution	An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.	null
C0000610	inverse_isa	C0039536	6-Aminonicotinamide	Teratogens	A vitamin antagonist which has teratogenic effects.	An agent that causes the production of physical defects in the developing embryo.
C0000610	mapped_to	C0537676	6-Aminonicotinamide	PMA protocol	A vitamin antagonist which has teratogenic effects.	null
C0000610	used_for	C0002585	6-Aminonicotinamide	Aminopyridines	A vitamin antagonist which has teratogenic effects.	Pyridines substituted in any position with an amino group. May be hydrogenated but must retain at least one double bond.
C0000610	inverse_isa	C0034541	6-Aminonicotinamide	Radiation-Sensitizing Agents	A vitamin antagonist which has teratogenic effects.	Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.
C0000610	subset_includes_concept	C1880653	6-Aminonicotinamide	FDA Established Names and Unique Ingredient Identifier Codes Terminology	A vitamin antagonist which has teratogenic effects.	The terminology that includes terms pertaining to FDA/USP Substance Registration System (SRS), which is to support health information technology initiatives by generating unique ingredient identifiers (UNIIs) for substances in drugs, biologics, foods, and devices.
C0000617	mapped_to	C0045396	6-Ketoprostaglandin F1 alpha	2,3-dinor-6-ketoprostaglandin F1alpha	The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue.	A beta-oxidation product of 6-keto prostaglandin F1 alpha (PGF1a) and the major urinary metabolite of prostaglandin I2 (prostacyclin, PGI2). 2,3-dinor-6-ketoprostaglandin F1alpha in urine is often used as a correlative marker to indirectly measure prostacyclin production.
C0000617	mapped_to	C0049405	6-Ketoprostaglandin F1 alpha	6,15-diketo-13,14-dihydroprostaglandin F1alpha	The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue.	null
C0000617	mapped_to	C0049406	6-Ketoprostaglandin F1 alpha	6,15-diketoprostaglandin F1alpha	The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue.	null
C0000617	mapped_to	C0174466	6-Ketoprostaglandin F1 alpha	delta(17)-6-ketoprostaglandin F1alpha	The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue.	null
C0000617	mapped_to	C0533162	6-Ketoprostaglandin F1 alpha	endothelin-1,2-6-keto-PGF1-alpha	The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue.	null
C0000617	mapped_to	C0624375	6-Ketoprostaglandin F1 alpha	6-ketoprostaglandin F1 alpha-tyramide	The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue.	null
C0000617	mapped_to	C0635726	6-Ketoprostaglandin F1 alpha	6-ketoprostaglandin F1 alpha-thyroglobulin conjugate	The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue.	null
C0000617	mapped_to	C0647369	6-Ketoprostaglandin F1 alpha	5-hydroxy-6-ketoprostaglandin F1 alpha	The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue.	null
C0000617	inverse_isa	C0033554	6-Ketoprostaglandin F1 alpha	Prostaglandins	The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue.	A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes.
C0000617	subset_includes_concept	C3899741	6-Ketoprostaglandin F1 alpha	CTRP Terminology	The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue.	Terminology that is used to support NCI's Clinical Trials Reporting Program (CTRP), a database that captures the required reporting data for all NCI-sponsored clinical trials.
C0000617	subset_includes_concept	C4684827	6-Ketoprostaglandin F1 alpha	CTRP Biomarker Terminology	The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue.	A set of terms that is comprised of the biomarkers referenced in NCI-sponsored clinical trials.
C0000617	inverse_isa	C0033561	6-Ketoprostaglandin F1 alpha	Prostaglandins F	The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue.	(9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes thr...
C0000617	replaced_by	C0312528	6-Ketoprostaglandin F1 alpha	6-Ketoprostaglandin PGF1	The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue.	null
C0000618	has_ingredient	C0689485	mercaptopurine	mercaptopurine 50 MG Oral Tablet	An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia.	null
C0000618	has_ingredient	C3817479	mercaptopurine	mercaptopurine 20 MG/ML Oral Suspension	An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia.	null

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.